JSLS : Journal of the Society of Laparoendoscopic…
BACKGROUND AND OBJECTIVES
Alvimopan, a peripherally acting mu-opioid receptor antagonist, decreased time to gastrointestinal recovery and hospital length of stay in open bowel resection patients in Phase 3 trials. However, the benefit in laparoscopic colectomy patients remains unclear.
A retrospective case series review was performed to study… (More)